This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. MEMPHIS, Tenn. — In just the second week of ...
SAN DIEGO — The next advance in spinal cord stimulation (SCS) could be a closed-loop system that uses evoked compound action potentials (ECAPs) to maintain therapeutic activation, results of the phase ...
Abbott Laboratories ABT recently received FDA approval for its Eterna spinal cord stimulation (SCS) system for treating chronic pain. The Eterna SCS system is the smallest implantable, rechargeable ...
It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...
The Senza SCS System is a neuromodulation device designed to deliver electrical stimulation using implantable leads and a rechargeable, implantable pulse generator. The Food and Drug Administration ...
DUBLIN, Dec. 9, 2019 /PRNewswire/ -- The "Global Spinal Cord Stimulation (SCS) Market: Size, Trends & Forecasts (2019-2023)" report has been added to ResearchAndMarkets.com's offering. Global Spinal ...
High expectations from the spinal cord stimulation space are driving the stock. The space should get more competitive and Nuvectra’s listing may draw attention towards the same. The stock may trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback